Anthos Therapeutics to Be Acquired by Novartis for Up to $3.1 Billion
February 12, 2025
February 12, 2025
BOSTON, Massachusetts, Feb. 12 -- Goodwin, a law firm, issued the following news release:
* * *
Anthos Therapeutics To Be Acquired by Novartis For Up To $3.1 Billion
The Life Sciences and M&A teams advised Anthos Therapeutics in its agreement to be acquired by Novartis for up to $3.1 billion. Anthos was founded by Blackstone Life Sciences and Novartis in 2019 with the exclusive global rights from Novartis to develop, manufacture, and commercialize abela . . .
* * *
Anthos Therapeutics To Be Acquired by Novartis For Up To $3.1 Billion
The Life Sciences and M&A teams advised Anthos Therapeutics in its agreement to be acquired by Novartis for up to $3.1 billion. Anthos was founded by Blackstone Life Sciences and Novartis in 2019 with the exclusive global rights from Novartis to develop, manufacture, and commercialize abela . . .